(Stroke. 2002;33:2376.)
© 2002 American Heart Association, Inc.
Original Contributions |
From the Departments of Neurology (W.T.L.), Epidemiology (W.T.L.), and Biostatistics (C.D.), University of Washington, Seattle; Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Md (T.A.M.); Department of Pathology, University of Vermont, Colchester (M.R.L.); Department of Radiology, Johns Hopkins University, Baltimore, Md (N.J.B.); Department of Radiology, TuftsNew England Medical Center, Boston, Mass (D.O.); and Departments of Radiology (J.C.) and Public Health Sciences (C.D.F.), Wake Forest University, Winston-Salem, NC.
Correspondence to W.T. Longstreth, Jr, MD, Department of Neurology, Box 359775, Harborview Medical Center, 325 Ninth Ave, Seattle WA 98104-2499. E-mail wl{at}u.washington.edu
| Abstract |
|---|
|
|
|---|
Methods The Cardiovascular Health Study (CHS) is a population-based, longitudinal study of 5888 people aged
65 years. Participants have had extensive baseline and follow-up evaluations; 1433 participants underwent 2 MRI scans separated by 5 years and had no infarcts on initial MRI.
Results On follow-up MRI, 254 participants (17.7%) had 1 or more infarcts. Most were single (75.6%), subcortical (79.9%), and small (3 to 20 mm in 87.0%). Only 11.4% of those with infarcts experienced a documented transient ischemic attack or stroke between the scans. Although participants were similar at initial MRI, those with MRI-defined infarcts on follow-up experienced greater decline than those without infarcts on the Modified Mini-Mental State Examination and Digit-Symbol Substitution test (both P<0.01). Severity of white matter changes on initial MRI was the strongest predictor of incident infarcts. When it was excluded from stepwise multivariable models, predictors were serum creatinine, age, and ankle-arm index.
Conclusions Incident MRI-defined infarcts commonly affect the elderly. Most are small, subcortical, and not associated with acute symptoms recognized as a transient ischemic attack or stroke. Nonetheless, they cannot be considered silent because of their association with subtle cognitive deficits. These covert infarcts are associated with white matter changes, which may share a common pathophysiology. Whether control of vascular risk factors, such as blood pressure, would reduce the risk of developing these infarcts and associated cognitive decline deserves further investigation.
Key Words: brain infarction creatinine incidence leukoariosis magnetic resonance imaging
| Introduction |
|---|
|
|
|---|
Wanting to avoid descriptors such as "silent" or "benign," we use "covert" to describe infarcts discovered in people without a history of transient ischemic attack or stroke. Although overt infarcts cause acute symptoms or signs that are clinically recognized as transient ischemic attack or acute stroke, covert infarcts do not. Rather, they may be associated with subtle neurological deficits. For the elderly, overt infarcts may be less common manifestations of cerebrovascular disease than covert infarcts. Although risk factors for overt infarcts have been evaluated extensively, risk factors for covert infarcts have not. Prevention of covert brain infarcts would reduce the incidence of a condition that commonly affects elderly people, eroding brain function and increasing the risk for more dramatic loss of brain function that occurs with acute stroke.
The Cardiovascular Health Study (CHS) is a population-based, longitudinal study of coronary and cerebrovascular disease in 5888 participants aged
65 years. As part of their comprehensive evaluation, 3660 participants underwent an initial cranial MRI, of whom 2116 underwent a follow-up MRI 5 years later. Of these, a subset of 1433 participants had no infarcts on their initial MRI. With this pair of MRI scans in 1433 participants, we sought to explore the incidence, manifestations, and predictors of MRI-defined infarcts.
| Subjects and Methods |
|---|
|
|
|---|
65 years, able to give informed consent, and able to respond to questions without the aid of a surrogate respondent. More details about the study design and characteristics of the 5888 participants are published elsewhere.8,9
Evaluations
Eligible and consenting participants underwent an extensive baseline evaluation including questionnaires, physical examination, and laboratory testing.4,8,9 A Doppler stethoscope and a standard mercury manometer were used to measure the posterior tibial and brachial systolic blood pressures, from which the ankle-arm index was calculated.10 Subjects cognitive functions were evaluated with the use of a Modified Mini-Mental State Examination11 and the Digit-Symbol Substitution test.12 Questionnaires were used to assess activities of daily living, instrumental activities of daily living, and depression. Parts of the baseline evaluation have been repeated annually. Variables considered in these analyses as potential risk factors were those from the examination closest in time to the brain imaging. Participants were screened for a history of transient ischemic attack or stroke before the initial MRI13 but were not excluded if they had such events.
Brain Imaging
Cranial MRI scanning protocol included sagittal T1-weighted localizer images and axial T1, spin density, and T2-weighted images. All axial images had 5-mm thickness and no interslice gaps.4,14 Without knowledge of any clinical information, neuroradiologists at the reading center identified infarcts and estimated the white matter, ventricular, and sulcal grades using a 10-point system, as detailed previously.4,14 A brain infarct was defined as an area of abnormal signal intensity in a vascular distribution that lacked mass effect. Infarcts had to be hyperintense to gray matter on both spin density and T2-weighted images. To be considered infarcts in the white matter and brain stem, lesions also had to be hypointense on T1-weighted images, with intensities approaching that of cerebrospinal fluid. Because abnormalities <3 mm could not be reliably detected, all infarcts in these analyses had to be
3 mm. Lacunes were defined as subcortical infarcts 3 to 20 mm in size.4
All members of the CHS cohort were invited to undergo MRI scanning, and 3660 (62%) were scanned. They were younger and healthier than those who did not undergo MRI.14 All members were again invited to undergo MRI 5 years later. The 2116 participants who underwent 2 scans were healthier than the 1544 who underwent a single scan (Table 1). The initial MRI of the 2116 participants with 2 scans showed the following: 1 or more infarcts in 568 (26.8%); only abnormalities measuring <3 mm in 108 (5.1%); and only evidence for a prior hemorrhage in 7 (0.3%). These 683 participants were excluded, leaving 1433 whose initial MRI showed no infarcts. The 108 participants whose scans only showed abnormalities <3 mm were excluded just in case some of these lesions represented true infarcts. The initial scans were performed from November 1991 to May 1994, and follow-up scans were performed from May 1997 to December 1999. The time between a participants initial and follow-up scan varied between 3.2 and 7.5 years, with a median and mean of 5.0 years. Neuroradiologists at the reading center are still collecting data on the change in white matter grade between the 2 scans.
|
Analyses
Participants whose follow-up MRI showed 1 or more infarcts were classified as having incident MRI-defined brain infarct. Cognitive and motor tests performed close in time to the initial scan and to the follow-up scan were compared with the use of ANCOVA on the second measure, controlling for the first measure and for the time between scans. Finally, potential risk factors were sought for incident infarcts. We examined those factors evaluated in previous CHS reports seeking (1) cross-sectional associations with MRI-defined brain infarcts4 and (2) longitudinal associations with incident stroke.13 Factors were evaluated with Fisher exact,
2, and t tests, as appropriate. Factors with significant associations (P<0.05) were eligible for multivariable models with the use of forward stepwise logistic regression in which the outcome variable was incident brain infarct, the P value to enter was set at 0.05, and the P value to remove was set at 0.10. We also controlled for the time between the scans, as a continuous variable, in all models. Results were similar when all factors, regardless of whether they were significantly associated with MRI-defined incident infarcts, were available for the multivariable models. SPSS for Windows, version 10.0.7, was used for these analyses,15 which were based on the updated CHS database incorporating minor corrections through January 2001.
| Results |
|---|
|
|
|---|
|
Although between the scans, 39 participants were adjudicated as meeting criteria for stroke, follow-up MRI showed evidence for any infarct or bleed in only 23 of the 39 (59.0%). For the 18 participants who were adjudicated as meeting criteria for a transient ischemic attack, follow-up MRI showed evidence for any infarct or bleed in 7 of the 18 (38.9%). Two participants were adjudicated as meeting criteria for a transient ischemic attack and stroke. Only 29 (11.4%) of the 254 participants whose follow-up MRI showed at least 1 infarct had experienced a transient ischemic attack or stroke between the scans.
Manifestations
Associations with performance measures are shown in Table 3. Although scores on the Modified Mini-Mental State Examination and the Digit-Symbol Substitution test were similar at the initial scan, at the follow-up scan, deterioration of cognitive performance was significantly greater in those with an incident MRI-defined infarct compared with those without. Changes in depression scores, number of finger taps in 15 seconds, and time to walk 4.6 m (15 ft) were not significantly different between the 2 groups at the initial or follow-up scan. Results for measures of cognitive performance remained significant after the 55 participants who were adjudicated as having a transient ischemic attack or stroke between the scans were excluded from the analyses.
|
Predictors
Only 9 of the 68 variables from around the time of the initial scan that we evaluated were significantly related to incident MRI-defined brain infarct (Table 4). Components of the ankle-arm index were examined separately. Brachial systolic blood pressure was significantly related to incident infarct, while posterior tibial systolic blood pressure was not. Other variables examined and not found to be significantly different are listed in the footnote to Table 4. Of note, having a transient ischemic attack or stroke before the initial MRI (n=47) was not associated with incident brain infarct, which occurred in 23.4% of the 47 with a previous event and 17.5% of the 1386 without a previous event (P>0.05).
|
In multivariable model 1, we allowed all of 9 variables, as coded in Table 4, to compete in a stepwise fashion for entry. Only 2 variables entered: creatinine as a continuous variable (odds ratio [OR], 2.09; 95% CI, 1.21 to 3.60) and white matter grade (OR, 1.57; 95% CI, 1.40 to 1.75). Because the same factors that increased the risk of brain infarcts could increase the risk of white matter changes,2,4,14 the MRI variables were withheld from model 2. Three variables entered: creatinine (OR, 1.77; 95% CI, 1.03 to 3.04), age (OR, 1.04; 95% CI, 1.01 to 1.07), and ankle-arm index (OR, 0.36; 95% CI, 0.14 to 0.88). To allow greater ease in interpreting the results, we recoded creatinine, age, and ankle-arm index into quintiles on the basis of participants with incident infarcts. White matter grades 4 through 9 were collapsed into 1 category (4+) because of small numbers. In grade 4, 26 of 62 (41.9%) had incident infarcts; grade 5, 9 of 27 (33.3%); grade 6, 3 of 7 (42.9%); grade 7, 4 of 5 (80.0%); grade 8, 2 of 4 (50.0%); and grade 9, 0 of 0. Using these categorical variables, we repeated model 1, forcing in creatinine and white matter grade, and model 2, forcing in creatinine, age, and ankle-arm index (Table 5).
|
Cortical Infarcts
For the 36 participants whose incident MRI-defined infarcts were solely cortical (Table 2), we contrasted their findings on ECG, echocardiography, and carotid ultrasonography with those of participants whose MRI showed no infarcts (n=1179) or showed infarcts that were not solely cortical (n=218). The only variable significantly different across the 3 groups was ECG evidence of atrial fibrillation. It was present in 13.9% of participants with solely cortical infarcts, 1.5% of those without infarcts, and 1.4% of those with infarcts that were not solely cortical (P<0.001). Of the 26 participants with atrial fibrillation on ECG done around the time of the initial MRI, 8 (30.8%) had an incident MRI-defined infarct on their follow-up scan. Five were solely cortical, and the other 3 were lacunes.
| Discussion |
|---|
|
|
|---|
The findings of the present longitudinal study support the findings of cross-sectional studies that these infarcts cannot be considered silent or benign.3,4 Those with follow-up MRI demonstrating infarcts had significantly worse cognitive performance at follow-up than those without infarcts despite the 2 groups having similar cognitive performance at the time of the initial MRI. These analyses cannot address whether incident infarcts themselves or other processes associated with infarcts, such as changes in white matter grade over time, cause the cognitive decline. One could argue that the differences in scores were statistically significant but not clinically important. Nonetheless, if one assumes a linear decline in the Mini-Mental State Examination score in the participants without MRI-defined infarcts (-0.9 points over 5 years), they would experience over 13 years the same decline seen in participants with MRI-defined infarcts in only 5 years. Detailed cognitive testing was not done in this study but will be necessary to better define the importance of these findings.
Of the many potential risk factors evaluated, only 9 were significantly related to having an incident MRI-defined infarct on follow-up MRI. The strongest association was for white matter grade. White matter changes and brain infarcts, both overt and covert, share many risk factors,2,4,14 suggesting that they may represent different manifestations of cerebrovascular disease. If so, the presence of one could increase the risk of the other. This study cannot address the question of whether associations found for incident MRI-defined infarcts are mediated through changes in the white matter grade between the 2 scans because these data are still being collected.
When white matter grade was withheld from multivariable models, age, creatinine, and ankle-arm index were significantly and independently associated with developing an incident infarct. Creatinine has been associated in a cross-sectional study with prevalent MRI-defined infarcts4 and in 2 longitudinal studies with incident stroke.13,17 The risk was higher for those with creatinine of
115 µmol/L (1.3 mg/dL). The association with creatinine may simply reflect the deleterious effects of hypertension on a vascular bed other than the brain, although direct effects of renal insufficiency on small vessels have also been proposed.18 In addition, renal insufficiency is associated with elevated plasma homocysteine levels,19 which in turn have been associated with covert infarcts and white matter changes.5,20,21 In this study the ankle-arm index was also an independent risk factor for incident brain infarction, as it has been for incident myocardial infarction22 and ischemic stroke.23 The association with ankle-arm index may reflect the effects of elevated systolic blood pressure, peripheral arterial disease, or both. Evidence that the peripheral vasculature is affected likely increases the chances that other arterial trees are affected, such as those supplying the brain and heart.
Of note, diabetes and cigarette smoking were not associated with incident MRI-defined infarcts, consistent with prior cross-sectional studies in which these factors were associated only with symptomatic infarcts.4,6 In addition, the few participants (n=47) with a history of transient ischemic attack or stroke before the initial MRI were not at increased risk of incident MRI-defined infarcts compared with participants without such a history. Possibly the history was in error in that the initial MRI was free of infarcts.
Only 36 (2.5%) of the 1433 participants had incident brain infarcts solely involving the cerebral cortex. We suspected that these participants were more likely to have had an embolic event. A significant association was found with atrial fibrillation on ECG done close in time to the initial MRI but not carotid ultrasound measures. These findings confirm the importance of atrial fibrillation as a risk factor for incident infarcts in the elderly, but for a relatively uncommon type of infarct.
This study has its limitations. Participants in CHS, and especially those included in these analyses, are likely healthier than the general population of elderly people. Although MRI was performed on a large number of elderly people and interpreted in a standard fashion without any clinical information, we do not know that the findings being interpreted as infarcts on the MRI are in fact brain infarcts and that the white matter changes do not include some infarcts. We have no MRI-pathological correlation and are unlikely to have such information given the low rate of autopsies in CHS. Nonetheless, prior studies have shown good MRI-pathological correlation,24 and we assume that subcortical lesions on MRI are a consequence of ischemia in the distribution of penetrating arteries. Finally, risk factor status could have changed between the initial MRI and the incident infarct, and participants may have been misclassified on the basis of information from around the time of the initial scan. Only more frequent brain imaging could diminish such misclassification in future studies.
In this study incident covert brain infarcts were common in the elderly and associated with a deterioration of cognitive function. Brain infarcts were associated with both risk factors for and evidence of disease in other vascular beds, specifically the renal and peripheral vasculature. We suspect that measures directed at preventing vascular disease might have the additional salutary effect of preserving cognition with aging, as suggested in a trial of treating systolic hypertension.25 Future trials aimed at preventing vascular disease should consider assessing serial cranial MRI and cognitive function as outcome measures.
| Acknowledgments |
|---|
| Footnotes |
|---|
| Appendix |
|---|
|
|
|---|
Received February 12, 2002; revision received May 15, 2002; accepted May 27, 2002.
| References |
|---|
|
|
|---|
2. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997; 28: 19321939.
3. Price TR, Manolio TA, Kronmal RA, Kittner SJ, Yue NC, Robbins J, Anton-Culver H, OLeary DH. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults: the Cardiovascular Health Study. Stroke. 1997; 28: 11581164.
4. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol. 1998; 55: 12171225.
5. Matsui T, Arai H, Yuzuriha T, Yao H, Miura M, Hashimoto S, Higuchi S, Matsushita S, Morikawa M, Kato A, Sasaki H. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke. 2001; 32: 11161119.
6. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2002; 33: 2125.
7. Bernick C, Kuller L, Dulberg C, Longstreth WT Jr, Manolio T, Beauchamp N, Price T. Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology. 2001; 57: 12221229.
8. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, OLeary DH, Psaty B, Rautaharju P, Tracy RP, Weiler PG. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991; 1: 263276.[Medline] [Order article via Infotrieve]
9. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol. 1993; 3: 358366.[Medline] [Order article via Infotrieve]
10. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D, for the Cardiovascular Health Study Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999; 19: 538545.
11. Teng EL, Chui HC. The Modified Mini-Mental State (3 MS) Examination. J Clin Psychiatry. 1987; 48: 314318.[Medline] [Order article via Infotrieve]
12. Salthouse TA. The role of memory in the age decline in digit-symbol substitution performance. J Gerontol. 1978; 33: 232238.
13. Manolio TA, Kronmal RA, Burke GL, OLeary DH, Price TR. Short-term predictors of incident stroke in older adults: the Cardiovascular Health Study. Stroke. 1996; 27: 14791486.
14. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, OLeary D, Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke. 1996; 27: 12741282.
15. Norusis M. SPSS for Windows: Advanced Statistics Release 6.0. Chicago, Ill: SPSS Inc; 1993.
16. Walters RJ, Holmes PA, Thomas DJ. Silent cerebral ischaemic lesions and atrophy in patients with apparently transient cerebral ischaemic attacks. Cerebrovasc Dis. 2000; 10 (suppl 4): 1213.
17. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke. 1997; 28: 557563.
18. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertensive cerebral small-vessel disease: an autopsy study. Stroke. 1997; 28: 22222229.
19. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int. 1999; 55: 10281035.[CrossRef][Medline] [Order article via Infotrieve]
20. Fassbender K, Mielke O, Bertsch T, Nafe B, Froschen S, Hennerici M. Homocysteine in cerebral macroangiography and microangiopathy. Lancet. 1999; 353: 15861587.[CrossRef][Medline] [Order article via Infotrieve]
21. van Dijk EJ, Vermeer SE, den Heijer T, Oudkerk M, Hofman A, Koudstaal PJ, Clarke R, Breteler MMB. Homocysteine and cerebral white matter lesions: the Rotterdam Scan Study. Stroke. 2001; 32: 321.Abstract.
22. Psaty BM, Furberg CD, Kuller LH, Bild DE, Rautaharju PM, Polak JF, Bovill E, Gottdiener JS. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med. 1999; 159: 13391347.
23. Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke. 2001; 32: 17211724.
24. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993; 43: 16831689.
25. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998; 352: 13471351.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
X. Chen, W. Wen, K. J. Anstey, and P. S. Sachdev Prevalence, incidence, and risk factors of lacunar infarcts in a community sample Neurology, July 28, 2009; 73(4): 266 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Minati, T. Edginton, M. Grazia Bruzzone, and G. Giaccone Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review American Journal of Alzheimer's Disease and Other Dementias, April 1, 2009; 24(2): 95 - 121. [Abstract] [PDF] |
||||
![]() |
A. Viswanathan, W. A. Rocca, and C. Tzourio Vascular risk factors and dementia: How to move forward? Neurology, January 27, 2009; 72(4): 368 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Johnston The 2008 William M. Feinberg Lecture: Prioritizing Stroke Research Stroke, December 1, 2008; 39(12): 3431 - 3436. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. van Dijk, N. D. Prins, H. A. Vrooman, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study Stroke, October 1, 2008; 39(10): 2712 - 2719. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Coutts, M. D. Hill, C. R. Campos, Y. B. Choi, S. Subramaniam, J. C. Kosior, A. M. Demchuk, and for the VISION study group Recurrent Events in Transient Ischemic Attack and Minor Stroke: What Events Are Happening and to Which Patients? Stroke, September 1, 2008; 39(9): 2461 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Virtanen, D. S. Siscovick, W. T. Longstreth Jr, L. H. Kuller, and D. Mozaffarian Fish consumption and risk of subclinical brain abnormalities on MRI in older adults Neurology, August 5, 2008; 71(6): 439 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fornage, Y. A. Chiang, E. S. O'Meara, B. M. Psaty, A. P. Reiner, D. S. Siscovick, R. P. Tracy, and W.T. Longstreth Jr Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study Stroke, July 1, 2008; 39(7): 1952 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Newman, R. M. Boudreau, B. L. Naydeck, L. F. Fried, and T. B. Harris A Physiologic Index of Comorbidity: Relationship to Mortality and Disability J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2008; 63(6): 603 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ikram, M. van Oijen, F. J. de Jong, J. A. Kors, P. J. Koudstaal, A. Hofman, J. C.M. Witteman, and M. M.B. Breteler Unrecognized Myocardial Infarction in Relation to Risk of Dementia and Cerebral Small Vessel Disease Stroke, May 1, 2008; 39(5): 1421 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Steffens, H. Chung, K. R. R. Krishnan, W.T. Longstreth Jr, M. Carlson, and G. L. Burke Antidepressant Treatment and Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study Stroke, March 1, 2008; 39(3): 857 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Schneider, Z. Arvanitakis, W. Bang, and D. A. Bennett Mixed brain pathologies account for most dementia cases in community-dwelling older persons Neurology, December 11, 2007; 69(24): 2197 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khatri, C. B. Wright, T. L. Nickolas, M. Yoshita, M. C. Paik, G. Kranwinkel, R. L. Sacco, and C. DeCarli Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) Stroke, December 1, 2007; 38(12): 3121 - 3126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Vernooij, M. A. Ikram, H. L. Tanghe, A. J.P.E. Vincent, A. Hofman, G. P. Krestin, W. J. Niessen, M. M.B. Breteler, and A. van der Lugt Incidental Findings on Brain MRI in the General Population N. Engl. J. Med., November 1, 2007; 357(18): 1821 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF] |
||||
![]() |
W. Longstreth Jr., E. K. M. Larsen, R. Klein, T. Y. Wong, A. R. Sharrett, D. Lefkowitz, and T. A. Manolio Associations between Findings on Cranial Magnetic Resonance Imaging and Retinal Photography in the Elderly: The Cardiovascular Health Study Am. J. Epidemiol., January 1, 2007; 165(1): 78 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hachinski, C. Iadecola, R. C. Petersen, M. M. Breteler, D. L. Nyenhuis, S. E. Black, W. J. Powers, C. DeCarli, J. G. Merino, R. N. Kalaria, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Stroke, September 1, 2006; 37(9): 2220 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Elkins, W. T. Longstreth Jr, T. A. Manolio, A. B. Newman, R. A. Bhadelia, and S. C. Johnston Education and the cognitive decline associated with MRI-defined brain infarct Neurology, August 8, 2006; 67(3): 435 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Djaiani Aortic arch atheroma: stroke reduction in cardiac surgical patients. Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2006; 10(2): 143 - 157. [Abstract] [PDF] |
||||
![]() |
D. S. Knopman Dementia and Cerebrovascular Disease Mayo Clin. Proc., February 1, 2006; 81(2): 223 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Leblanc, J. F. Meschia, D. T. Stuss, and V. Hachinski Genetics of Vascular Cognitive Impairment: The Opportunity and the Challenges Stroke, January 1, 2006; 37(1): 248 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Seliger, W.T. Longstreth Jr, R. Katz, T. Manolio, L. F. Fried, M. Shlipak, C. O. Stehman-Breen, A. Newman, M. Sarnak, D. L. Gillen, et al. Cystatin C and Subclinical Brain Infarction J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3721 - 3727. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.T. Longstreth Jr Brain Vascular Disease Overt and Covert Stroke, October 1, 2005; 36(10): 2062 - 2063. [Full Text] [PDF] |
||||
![]() |
D. S. Knopman, T. H. Mosley, D. J. Catellier, A. R. Sharrett, and for the Atherosclerosis Risk in Communities (ARIC) Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort Neurology, September 27, 2005; 65(6): 876 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Coutts, M. D. Hill, J. E. Simon, C. -H. Sohn, J. N. Scott, A. M. Demchuk, and for the VISION Study Group Silent ischemia in minor stroke and TIA patients identified on MR imaging Neurology, August 23, 2005; 65(4): 513 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Elkins, D. S. Knopman, K. Yaffe, and S. C. Johnston Cognitive function predicts first-time stroke and heart disease Neurology, May 24, 2005; 64(10): 1750 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Kuller, O. L. Lopez, W. J. Jagust, J. T. Becker, S. T. DeKosky, C. Lyketsos, C. Kawas, J.C.S. Breitner, A. Fitzpatrick, and C. Dulberg Determinants of vascular dementia in the Cardiovascular Health Cognition Study Neurology, May 10, 2005; 64(9): 1548 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Fox, H. A. Taylor Jr, E. J. Benjamin, J. Ding, P. R. Liebson, D. Arnett, E. M. Quin, and T. N. Skelton Left Ventricular Mass Indexed to Height and Prevalent MRI Cerebrovascular Disease in an African American Cohort: The Atherosclerotic Risk in Communities Study Stroke, March 1, 2005; 36(3): 546 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.T. Longstreth Jr, A. M. Arnold, N. J. Beauchamp Jr, T. A. Manolio, D. Lefkowitz, C. Jungreis, C. H. Hirsch, D. H. O'Leary, and C. D. Furberg Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study Stroke, January 1, 2005; 36(1): 56 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Elkins and S. C. Johnston Twinning hearts and minds Neurology, December 28, 2004; 63(12): 2211 - 2212. [Full Text] [PDF] |
||||
![]() |
J. S. Elkins, E. S. O'Meara, W. T. Longstreth Jr., M. C. Carlson, T. A. Manolio, and S. C. Johnston Stroke risk factors and loss of high cognitive function Neurology, September 14, 2004; 63(5): 793 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Shumaker, C. Legault, L. Kuller, S. R. Rapp, L. Thal, D. S. Lane, H. Fillit, M. L. Stefanick, S. L. Hendrix, C. E. Lewis, et al. Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women: Women's Health Initiative Memory Study JAMA, June 23, 2004; 291(24): 2947 - 2958. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Yousem, R. N. Bryan, N. J. Beauchamp Jr., and A. M. Arnold A National Neuroimaging Database: A Call to Action AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 908 - 909. [Full Text] [PDF] |
||||
![]() |
W. T. Longstreth Jr, R. Katz, J. Olson, C. Bernick, J. J. Carr, M. R. Malinow, D. L. Hess, M. Cushman, and S. M. Schwartz Plasma Total Homocysteine Levels and Cranial Magnetic Resonance Imaging Findings in Elderly Persons: The Cardiovascular Health Study Arch Neurol, January 1, 2004; 61(1): 67 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Streifler, M. Eliasziw, O. R. Benavente, S. Alamowitch, A. J. Fox, V. Hachinski, and H. J.M. Barnett Development and Progression of Leukoaraiosis in Patients With Brain Ischemia and Carotid Artery Disease Stroke, August 1, 2003; 34(8): 1913 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. DeCarli White matter changes, creatinine, age, and ankle arm index predicted incident MRI defined infarctions in older adults Evid. Based Med., July 1, 2003; 8(4): 121 - 121. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |